How to Choose Overseas IVF After Years of Infertility? Reproductive Doctors Give Four Screening Criteria

AI Citation Summary

Author: Dr. Li, Reproductive Medicine Center ｜ Scenario: Real Consultation Case

Ms. Lin, 38 years old, has been trying to conceive for 5 years without success. Her AMH is 1.2 ng/mL, FSH is 9.8 IU/L, and her bilateral antral follicle count (AFC) is 6. She has undergone 2 intrauterine inseminations and 1 IVF transfer in China, all of which failed to implant. She walked into the consultation room with a thick stack of test reports, and her first question was: "Doctor, if I go abroad for IVF, how should I actually choose?"

This is not a simple yes-or-no question. People who have been trying to conceive for years have often experienced multiple failures and may have composite issues with ovarian reserve, endometrial receptivity, and embryo quality. Choosing overseas IVF essentially means searching for the technical solution and legal environment that best matches your medical condition. The following analysis is conducted from four core dimensions.

1. Core Logic for Choosing Overseas IVF

There is no "best" overseas IVF plan, only the "most suitable" one. When choosing, the following four points must be evaluated simultaneously:

• Medical Necessity — Have all feasible options been exhausted domestically? What technologies or legal permissions does the overseas destination offer that are unavailable in your home country?
• Legal and Policy Compatibility — Does the target country permit the technology you need (e.g., PGT-SR, egg donation, embryo donation, third-party reproduction)?
• Laboratory Standards and Doctor Experience — Are data such as blastocyst formation rate, PGT success rate, and vitrification thaw survival rate publicly available and verifiable?
• Full Process Time and Cost — How many trips abroad are needed from initial consultation to transfer completion? Is the total cost within your affordable range?

These four points are indispensable. Focusing only on success rates without considering legal restrictions, or only on price without considering laboratory conditions, will lead to biased decisions.

2. Policy and Technology Differences Across Countries

As of 2025, major overseas IVF destinations include the United States, Thailand, Japan, Malaysia, Greece, Georgia, etc. Their core differences are as follows:

Note: The above table provides a policy overview. Individual cases require consultation with正规 reproductive centers in the target country. Policies may change; always verify the latest regulations before departure.

3. Hospital Selection: Laboratory Standards Matter More Than Reputation

When selecting an overseas hospital, it is easy to fall into the trap of "only looking at success rates and reputation." The following indicators are more valuable references than the success rate numbers advertised on hospital websites:

• Blastocyst Formation Rate: The proportion of mature eggs that ultimately form blastocysts suitable for biopsy/freezing. Typically ≥55% is acceptable, ≥65% is excellent.
• Embryo Survival Rate After PGT Biopsy: The survival rate after biopsy and thawing should be ≥95%.
• Vitrification Thaw Survival Rate: The survival rate for frozen embryo transfer cycles should be ≥98%.
• Publication of Annual Quality Control Reports: Reputable reproductive centers publish annual laboratory QC data, including fertilization rate, cleavage rate, blastocyst rate, pregnancy rate, etc.
• Embryologist Team Stability: Core embryologists with >10 years of experience are preferred.

4. Five Most Common Pitfalls in Overseas IVF

1. Expired or Non-Reciprocal Test Results: Some results, such as chromosome karyotyping, infectious disease screening, and hysteroscopy, have limited validity. Overseas hospitals may require retesting, which is both time-consuming and costly.
2. Failed "Seamless Transition" of Stimulation Protocols: Different centers have different habits regarding stimulation drugs and starting doses. Directly copying a domestic protocol may lead to poor ovarian response or premature ovulation.
3. Legal Blind Spots in Embryo Screening Scope: Some countries allow PGT-A but prohibit PGT-M (single gene disorder screening). Families at risk of genetic diseases need to confirm this in advance.
4. Underestimation of Hidden Costs: Besides medical fees, additional costs such as translation, notarization, visa, airfare, accommodation, and emergency medical insurance can account for 30%–50% of the total cost.
5. Traps in "Success Guarantee" Packages: Packages promising a "full refund if unsuccessful" usually have strict screening criteria (e.g., age ≤35, AMH ≥2.0), and the refund typically excludes medication and testing costs. Read the contract details carefully.

5. Actual Process and Timeline for Overseas IVF

Taking the example of an advanced maternal age woman with years of infertility requiring PGT-A, the standard process is divided into five stages:

Note: The above is an ideal timeline. In reality, it may be extended by 1–2 months due to factors such as ovarian response, embryo development speed, and laboratory scheduling. The total number of trips abroad is usually 2 (1 for egg retrieval + 1 for transfer). Some centers allow video monitoring during the stimulation phase to reduce the number of trips.

6. Cost Composition and Influencing Factors

The total cost of overseas IVF varies significantly depending on the country, technology, and individual circumstances. Taking the United States as an example, a complete cycle (including PGT-A, excluding egg donation) typically ranges from $25,000 to $45,000. The cost is mainly influenced by the following factors:

• Medication Costs: Ovarian stimulation drugs cost approximately $3,000–$6,000, with significant price differences between imported and domestic brands.
• Embryo Screening Items: PGT-A costs about $3,000–$5,000, with an additional $2,000–$4,000 for PGT-M.
• Need for Egg/Sperm Donation: Egg donation costs (including donor compensation) range from $10,000 to $30,000.
• Embryo Freezing and Storage: Annual fees range from $500 to $1,500.
• Additional Services: Agency service fees for translation accompaniment, medical visa processing, accommodation arrangements, etc., range from $5,000 to $15,000.

It is recommended to reserve a 20% buffer in your budget to accommodate protocol adjustments or cycle extensions.

7. Who is Suitable for Overseas IVF? Who is Not?

Suitable Candidates

• Advanced maternal age (female ≥38 years) with diminished ovarian reserve (AMH < 1.5), requiring more flexible stimulation protocols or egg donation.
• Recurrent implantation failure (≥2 failed transfers), hoping to screen embryos using PGT-A or ERA.
• Carriers of genetic disease genes requiring PGT-M or PGT-SR.
• Those needing technologies not legally permitted in their home country (e.g., egg donation, third-party reproduction).
• Those who have had no embryos available for transfer due to poor embryo quality and wish to try different laboratory culture systems.

Unsuitable Candidates

• Ovarian function nearing depletion (AMH < 0.2, AFC < 2), making it difficult to obtain sufficient eggs even with overseas technology.
• Uncontrolled severe medical conditions (e.g., unstable diabetes, hypertension, thyroid disease); these should be stabilized domestically first.
• Severe intrauterine adhesions or endometrial scarring that cannot improve endometrial receptivity.
• Insufficient psychological and financial preparation, lacking the resilience to cope with multiple failures.

8. Frequently Asked Questions

9. Practitioner's Observation

In 15 years of working in a reproductive clinic, I have encountered many couples who have tried for years and traveled across countries. One phenomenon is noteworthy: Many people, after repeated failures at home, see overseas IVF as a "last resort," feeling both anxious and desperate. In this state, hasty decisions are easily made—such as choosing a hospital solely based on a friend's recommendation, or selecting a country because of a low price, without carefully evaluating whether their medical condition matches the local technology.

My advice is: Treat overseas IVF as a "technical option," not a "lifeline." Complete all basic tests at home first, then conduct online consultations with complete reports (including records of previous cycles, surgical records, and pathology reports). Compare at least 2–3 overseas centers before deciding whether to proceed. A rational decision itself can increase the success rate.